An Immunocompetent Mouse Model of Zika Virus Infection.

Matthew J. Gorman,Elizabeth A. Caine,Konstantin Zaitsev,Matthew C. Begley,James Weger-Lucarelli,Melissa B. Uccellini,Shashank Tripathi,Juliet Morrison,Boyd L. Yount,Kenneth H. Dinnon,Claudia Ruckert,Michael C. Young,Zhe Zhu,Shelly J. Robertson,Kristin L. McNally,Jing Ye,Bin Cao,Indira U. Mysorekar,Gregory D. Ebel,Ralph S. Baric,Sonja M. Best,Maxim N. Artyomov,Adolfo Garcia-Sastre,Michael S. Diamond
DOI: https://doi.org/10.1016/j.chom.2018.04.003
IF: 31.316
2018-01-01
Cell Host & Microbe
Abstract:Progress toward understanding Zika virus (ZIKV) pathogenesis is hindered by lack of immunocompetent small animal models, in part because ZIKV fails to effectively antagonize Stat2-dependent interferon (IFN) responses in mice. To address this limitation, we first passaged an African ZIKV strain (ZIKV-Dak-41525) through Rag1(-/-) mice to obtain a mouse-adapted virus (ZIKV-Dak-MA) that was more virulent than ZIKV-Dak-41525 in mice treated with an anti-Ifnar1 antibody. A G18R substitution in NS4B was the genetic basis for the increased replication, and resulted in decreased IFN-beta production, diminished IFN-stimulated gene expression, and the greater brain infection observed with ZIKV-Dak-MA. To generate a fully immunocompetent mouse model of ZIKV infection, human STAT2 was introduced into the mouse Stat2 locus (hSTAT2 KI). Subcutaneous inoculation of pregnant hSTAT2 KI mice with ZIKV-Dak-MA resulted in spread to the placenta and fetal brain. An immunocompetent mouse model of ZIKV infection may prove valuable for evaluating countermeasures to limit disease.
What problem does this paper attempt to address?